• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌性阴道病治疗后卷曲乳杆菌或詹氏乳杆菌定植的行为预测因素:一项队列研究

Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study.

作者信息

Mitchell Caroline, Manhart Lisa E, Thomas Kathy, Fiedler Tina, Fredricks David N, Marrazzo Jeanne

机构信息

Harborview Women's Clinic, Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98105, USA.

出版信息

Infect Dis Obstet Gynecol. 2012;2012:706540. doi: 10.1155/2012/706540. Epub 2012 May 30.

DOI:10.1155/2012/706540
PMID:22693410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3369434/
Abstract

OBJECTIVE

Evaluate predictors of vaginal colonization with lactobacilli after treatment for bacterial vaginosis (BV).

METHODS

Vaginal fluid specimens from women with BV underwent qPCR for Lactobacillus crispatus, L. jensenii, and L. iners pre- and posttreatment.

RESULTS

Few women with BV were colonized with L. crispatus (4/44, 9%) or L. jensenii (1/44, 2%), though all had L. iners. One month posttreatment 12/44 (27%) had L. crispatus, 12/44 (27%) L. jensenii, and 43/44 (98%) L. iners. Presence of L. jensenii posttreatment was associated with cure (Risk Ratio (RR) 1.67; 95% CI 1.09-2.56); L. crispatus showed a similar trend (RR 1.41; 95% CI 0.89-2.24, P = 0.14). Receptive oral sex was associated with 2.2-log(10) lower concentration of L. crispatus (95% CI -4.38, -.02), and digital-vaginal sex with 2.6-log(10) lower concentration (95% CI -4.87, -.33).

CONCLUSION

One month after BV treatment, few women established colonization with L. crispatus or L. jensenii. Few behaviors were associated with colonization.

摘要

目的

评估细菌性阴道病(BV)治疗后阴道乳酸杆菌定植的预测因素。

方法

对患有BV的女性的阴道液标本在治疗前和治疗后进行卷曲乳酸杆菌、詹氏乳酸杆菌和惰性乳酸杆菌的定量聚合酶链反应(qPCR)检测。

结果

很少有BV女性被卷曲乳酸杆菌(4/44,9%)或詹氏乳酸杆菌(1/44,2%)定植,不过所有人都有惰性乳酸杆菌。治疗后1个月,12/44(27%)有卷曲乳酸杆菌,12/44(27%)有詹氏乳酸杆菌,43/44(98%)有惰性乳酸杆菌。治疗后詹氏乳酸杆菌的存在与治愈相关(风险比(RR)1.67;95%置信区间1.09 - 2.56);卷曲乳酸杆菌显示出类似趋势(RR 1.41;95%置信区间0.89 - 2.24,P = 0.14)。接受口交与卷曲乳酸杆菌浓度降低2.2个对数(10)相关(95%置信区间 - 4.38, - 0.02),指交与浓度降低2.6个对数(10)相关(95%置信区间 - 4.87, - 0.33)。

结论

BV治疗后1个月,很少有女性建立卷曲乳酸杆菌或詹氏乳酸杆菌定植。很少有行为与定植相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/3369434/b52155413efb/IDOG2012-706540.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/3369434/b52155413efb/IDOG2012-706540.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6e1/3369434/b52155413efb/IDOG2012-706540.001.jpg

相似文献

1
Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study.细菌性阴道病治疗后卷曲乳杆菌或詹氏乳杆菌定植的行为预测因素:一项队列研究
Infect Dis Obstet Gynecol. 2012;2012:706540. doi: 10.1155/2012/706540. Epub 2012 May 30.
2
Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.细菌性阴道病相关细菌和性行为对益生菌卷曲乳杆菌 CTV-05 阴道定植的影响。
Sex Transm Dis. 2011 Nov;38(11):1020-7. doi: 10.1097/OLQ.0b013e3182267ac4.
3
Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women.日本孕妇中乳酸杆菌属与细菌性阴道病相关细菌的关联以及细菌性阴道病评分
BMC Infect Dis. 2007 Nov 7;7:128. doi: 10.1186/1471-2334-7-128.
4
Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women.脆拟杆菌、惰性乳杆菌和阴道加德纳菌对孕妇阴道细菌组成的影响。
Arch Gynecol Obstet. 2021 Aug;304(2):395-400. doi: 10.1007/s00404-021-05978-z. Epub 2021 Feb 1.
5
Identification and characterisation of vaginal lactobacilli from South African women.鉴定和描述南非女性阴道乳杆菌。
BMC Infect Dis. 2013 Jan 26;13:43. doi: 10.1186/1471-2334-13-43.
6
Vaginal lactobacilli profile in pregnant women with normal & abnormal vaginal flora.孕妇正常和异常阴道菌群中的阴道乳杆菌谱。
Indian J Med Res. 2017 Oct;146(4):534-540. doi: 10.4103/ijmr.IJMR_774_16.
7
Association between vaginal washing and detection of by culture and quantitative PCR in HIV-seronegative Kenyan women: a cross-sectional analysis.阴道冲洗与肯尼亚 HIV 血清阴性女性中培养和定量 PCR 检测 的关系:一项横断面分析。
Sex Transm Infect. 2019 Sep;95(6):455-461. doi: 10.1136/sextrans-2018-053769. Epub 2019 Jan 29.
8
Lactobacillus species isolated from vaginal secretions of healthy and bacterial vaginosis-intermediate Mexican women: a prospective study.从健康和细菌性阴道病中间型墨西哥女性阴道分泌物中分离出的乳杆菌属:一项前瞻性研究。
BMC Infect Dis. 2013 Apr 26;13:189. doi: 10.1186/1471-2334-13-189.
9
Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis.健康女性与细菌性阴道病女性主要乳酸菌的比较。
Chin Med J (Engl). 2009 Nov 20;122(22):2748-51.
10
Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?无症状细菌性阴道病和外阴阴道假丝酵母菌病的阴道微生物群:它们与正常微生物群有何不同?
Microb Pathog. 2019 Sep;134:103599. doi: 10.1016/j.micpath.2019.103599. Epub 2019 Jun 15.

引用本文的文献

1
Microbiota effects and predictors of s colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trial.阴道用活生物疗法治疗后微生物群的影响及s定植的预测因素:一项随机、双盲、安慰剂对照试验的结果
medRxiv. 2025 Aug 30:2025.08.18.25333897. doi: 10.1101/2025.08.18.25333897.
2
Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment.阴道乳杆菌脂肪酸应答机制揭示了细菌性阴道病治疗的一种代谢物靶向策略。
Cell. 2024 Sep 19;187(19):5413-5430.e29. doi: 10.1016/j.cell.2024.07.029. Epub 2024 Aug 19.
3

本文引用的文献

1
Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species.对 HIV 血清阳性和阴性女性的生殖微生物组进行焦磷酸测序,结果显示,惰性乳杆菌是优势乳杆菌种。
Appl Environ Microbiol. 2011 Jan;77(1):378-81. doi: 10.1128/AEM.00973-10. Epub 2010 Nov 12.
2
Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.鼠李糖乳杆菌 GR-1 和罗伊氏乳杆菌 RC-14 预防或治疗 HIV 女性中的细菌性阴道病。
Int J Gynaecol Obstet. 2010 Dec;111(3):245-8. doi: 10.1016/j.ijgo.2010.07.008.
3
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis.
Draft genome sequences of three strains, isolated from the female urinary tract.
从女性尿道分离出的三株菌株的基因组序列草图。
Microbiol Resour Announc. 2024 Jul 18;13(7):e0033424. doi: 10.1128/mra.00334-24. Epub 2024 May 29.
4
The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).HPV、其他性传播感染和生殖道微生物组在宫颈微环境中的相互作用(MicroCervixHPV 研究)。
Front Cell Infect Microbiol. 2024 Mar 12;13:1251913. doi: 10.3389/fcimb.2023.1251913. eCollection 2023.
5
Vaginal fatty acid response mechanisms reveal a novel strategy for bacterial vaginosis treatment.阴道脂肪酸反应机制揭示了一种治疗细菌性阴道病的新策略。
bioRxiv. 2023 Dec 30:2023.12.30.573720. doi: 10.1101/2023.12.30.573720.
6
Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation.乳杆菌属的半胱氨酸依赖性是阴道微生物组调节的一个潜在治疗靶点。
Nat Microbiol. 2022 Mar;7(3):434-450. doi: 10.1038/s41564-022-01070-7. Epub 2022 Mar 3.
7
Reproductive tract microbiota of women in childbearing age shifts upon gynecological infections and menstrual cycle.育龄期女性生殖道微生物组在妇科感染和月经周期中发生变化。
BMC Microbiol. 2021 Sep 21;21(1):252. doi: 10.1186/s12866-021-02300-4.
8
Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.比较使用润滑剂前后与无保护阴道性交前后阴道细胞因子谱和微生物群:一项初步观察性研究。
BMC Infect Dis. 2021 Sep 18;21(1):973. doi: 10.1186/s12879-021-06512-x.
9
Sexually Transmitted Infections Treatment Guidelines, 2021.《2021年性传播感染治疗指南》
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
10
Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.宫颈上皮内瘤变手术后宫颈阴道微生物群和宫颈细胞因子谱的变化。
Sci Rep. 2021 Jan 25;11(1):2156. doi: 10.1038/s41598-020-80176-6.
人类阴道细菌的时间变异性与细菌性阴道病的关系。
PLoS One. 2010 Apr 15;5(4):e10197. doi: 10.1371/journal.pone.0010197.
4
Biosynthesis and degradation of H2O2 by vaginal lactobacilli.阴道乳杆菌产生和降解 H2O2 的研究。
Appl Environ Microbiol. 2010 Jan;76(2):400-5. doi: 10.1128/AEM.01631-09. Epub 2009 Nov 30.
5
Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.口服与阴道用甲硝唑治疗妊娠期细菌性阴道病的比较:对苛养菌的影响
BMC Infect Dis. 2009 Jun 10;9:89. doi: 10.1186/1471-2334-9-89.
6
Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora.孕期阴道微生物群的纵向分析表明,卷曲乳杆菌可促进正常阴道微生物群的稳定性,而加氏乳杆菌和/或惰性乳杆菌更易导致异常阴道微生物群的出现。
BMC Microbiol. 2009 Jun 2;9:116. doi: 10.1186/1471-2180-9-116.
7
Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.性生活和内源性乳酸杆菌会降低阴道中益生菌卷曲乳杆菌CTV-05的定植。
J Infect Dis. 2009 May 15;199(10):1506-13. doi: 10.1086/598686.
8
Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.单剂量替硝唑(2克)、鼠李糖乳杆菌GR-1和罗伊氏乳杆菌RC-14治疗细菌性阴道病的疗效改善:一项随机、双盲、安慰剂对照试验。
Can J Microbiol. 2009 Feb;55(2):133-8. doi: 10.1139/w08-102.
9
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.通过定量PCR评估甲硝唑阴道内给药治疗细菌性阴道病时阴道细菌浓度的变化。
J Clin Microbiol. 2009 Mar;47(3):721-6. doi: 10.1128/JCM.01384-08. Epub 2009 Jan 14.
10
Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.含乳酸杆菌阴道片治疗有症状细菌性阴道病的疗效
Clin Microbiol Infect. 2009 Jan;15(1):67-74. doi: 10.1111/j.1469-0691.2008.02112.x. Epub 2008 Nov 22.